Tuesday, November 30, 2021 9:57:34 AM
Cannaccord also estimate that Fy2022 revenue should be $ 49,57.
Source: https://ca.finance.yahoo.com/quote/BABY.V/analysis/
Additionnally, as per current financials, Else Cash position was C$13.8 million and the Company had no Loans liability as of September 30, 2021.
That quick analysis could very well be what is behind Hamutal Yitzhak’s comment saying: “Else is a company that should not yet be measured solely by Quarters. We are building a pathway to be a potential global leader in the plant-based nutrition arena and aiming for a multibillion-dollar market in 5 years. We are making great strides each quarter and have achieved significant milestones in this quarter including our Walmart.com and Kroger online partnerships. We also completed the development of two new product lines, and we expect momentum to continue and accelerate throughout the remainder of the year and beyond.”
I personally have all the shares I want to have (70% of my total portfolio) and as recommended I intend to 'HOLD'. Wasn't that committed to this I would recommend 'BUY'
Patiently,
Roger
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM